Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.

Wei JJ, Wu X, Peng Y, Shi G, Basturk O, Yang X, Daniels G, Osman I, Ouyang J, Hernando E, Pellicer A, Rhim JS, Melamed J, Lee P.

Clin Cancer Res. 2011 Mar 15;17(6):1297-305. doi: 10.1158/1078-0432.CCR-10-0993. Epub 2010 Dec 7. Erratum in: Clin Cancer Res. 2011 Aug 15;17(16):5523. Olca, Basturk [corrected to Basturk, Olca].

2.
3.

The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction.

Nagasaka K, Pim D, Massimi P, Thomas M, Tomaić V, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, Myers M, Banks L.

Oncogene. 2010 Sep 23;29(38):5311-21. doi: 10.1038/onc.2010.265. Epub 2010 Jul 12.

PMID:
20622900
4.

The leading edge during dorsal closure as a model for epithelial plasticity: Pak is required for recruitment of the Scribble complex and septate junction formation.

Bahri S, Wang S, Conder R, Choy J, Vlachos S, Dong K, Merino C, Sigrist S, Molnar C, Yang X, Manser E, Harden N.

Development. 2010 Jun;137(12):2023-32. doi: 10.1242/dev.045088.

5.

The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Zhao Q, Fan D.

Ann Surg. 2010 Jun;251(6):1056-63. doi: 10.1097/SLA.0b013e3181dd4ea9.

PMID:
20485139
6.

Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion.

Wu M, Pastor-Pareja JC, Xu T.

Nature. 2010 Jan 28;463(7280):545-8. doi: 10.1038/nature08702. Epub 2010 Jan 13. Erratum in: Nature. 2017 Mar 16;543(7645):452.

7.

Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast.

Bauer M, Su G, Casper C, He R, Rehrauer W, Friedl A.

Oncogene. 2010 Mar 25;29(12):1732-40. doi: 10.1038/onc.2009.463. Epub 2010 Jan 11.

8.

The microRNA network and tumor metastasis.

Zhang H, Li Y, Lai M.

Oncogene. 2010 Feb 18;29(7):937-48. doi: 10.1038/onc.2009.406. Epub 2009 Nov 23. Review.

PMID:
19935707
9.

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D.

Genes Dev. 2009 Sep 15;23(18):2152-65. doi: 10.1101/gad.1820109.

10.

MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.

Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X.

Clin Cancer Res. 2009 Sep 15;15(18):5744-52. doi: 10.1158/1078-0432.CCR-09-0385. Epub 2009 Sep 8.

11.

MicroRNAs in Cancer.

Garzon R, Calin GA, Croce CM.

Annu Rev Med. 2009;60:167-79. doi: 10.1146/annurev.med.59.053006.104707. Review.

PMID:
19630570
12.

Random versus directionally persistent cell migration.

Petrie RJ, Doyle AD, Yamada KM.

Nat Rev Mol Cell Biol. 2009 Aug;10(8):538-49. doi: 10.1038/nrm2729. Epub 2009 Jul 15. Review.

13.

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.

Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC.

Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12085-90. doi: 10.1073/pnas.0905234106. Epub 2009 Jul 13.

14.

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA.

Cell. 2009 Jun 12;137(6):1032-46. doi: 10.1016/j.cell.2009.03.047. Retraction in: Cell. 2015 Apr 9;161(2):417.

15.

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

Augello C, Caruso L, Maggioni M, Donadon M, Montorsi M, Santambrogio R, Torzilli G, Vaira V, Pellegrini C, Roncalli M, Coggi G, Bosari S.

BMC Cancer. 2009 Apr 27;9:125. doi: 10.1186/1471-2407-9-125.

16.

Vimentin regulates scribble activity by protecting it from proteasomal degradation.

Phua DC, Humbert PO, Hunziker W.

Mol Biol Cell. 2009 Jun;20(12):2841-55. doi: 10.1091/mbc.E08-02-0199. Epub 2009 Apr 22.

17.

Identification of potential driver genes in human liver carcinoma by genomewide screening.

Woo HG, Park ES, Lee JS, Lee YH, Ishikawa T, Kim YJ, Thorgeirsson SS.

Cancer Res. 2009 May 1;69(9):4059-66. doi: 10.1158/0008-5472.CAN-09-0164. Epub 2009 Apr 14.

18.

Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis.

Romagnoli S, Fasoli E, Vaira V, Falleni M, Pellegrini C, Catania A, Roncalli M, Marchetti A, Santambrogio L, Coggi G, Bosari S.

Am J Pathol. 2009 Mar;174(3):762-70. doi: 10.2353/ajpath.2009.080721. Epub 2009 Feb 13.

19.

Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.

Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK.

Cell. 2008 Nov 28;135(5):865-78. doi: 10.1016/j.cell.2008.09.045.

20.

Polarity proteins in migration and invasion.

Etienne-Manneville S.

Oncogene. 2008 Nov 24;27(55):6970-80. doi: 10.1038/onc.2008.347. Review.

PMID:
19029938

Supplemental Content

Support Center